Close Menu
Home › Saga Diagnostics Raises $4.2M

Saga Diagnostics Raises $4.2M

Jun 11, 2019

NEW YORK (GenomeWeb) — Swedish liquid biopsy firm Saga Diagnostics said today that it has raised SEK 40 million ($4.2 million) in venture financing.

Hadean Ventures led the round with participation from existing investors including Fårö Capital and the Gunnar Nilsson Cancer Foundation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25
Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

What's Popular?

In Molecular Diagnostics

  1. Liquid Biopsy Assay From MSKCC Approved by New York State

  2. SpeeDx, GSK Sign Test Supply, Development Deal

  3. Illumina Wins NIPT Infringement Suit Against Roche's Ariosa Diagnostics

  4. Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

    Premium

  5. At ASM Microbe, Stakeholders Discuss Reimbursement Issues for Multiplex Infectious Disease Tests

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.